Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, May 8, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Pharma
Aviva Biopharm Unveils Promising Preclinical Data for Safer Testosterone Therapy for Women at ENDO 2025
Life Sciences Times
-
July 14, 2025
0
Pharma
Amylyx Highlights Positive Avexitide Results for Post-Bariatric Hypoglycemia at ENDO 2025
Life Sciences Times
-
July 14, 2025
0
Pharma
Takeda Reports Breakthrough Phase 3 Results for Oveporexton in Narcolepsy Type 1
Life Sciences Times
-
July 14, 2025
0
Medtech
BEAR Implant Shows Promising ACL Repair Results in Real-World Study, Miach Orthopaedics Reports at AOSSM 2025
Life Sciences Times
-
July 14, 2025
0
Technology
RealSense Spins Out from Intel, Secures $50 Million to Expand AI Vision Tech for Robotics and Biometrics
Life Sciences Times
-
July 11, 2025
0
Biotech
Immunologist Dr. Hassan Abolhassani Joins Quince Therapeutics’ Scientific Advisory Board
Life Sciences Times
-
July 11, 2025
0
Biotech
Elegen and Nutcracker Therapeutics Launch Pilot for First Fully Cell-Free RNA Manufacturing Process in Cancer Treatment
Life Sciences Times
-
July 11, 2025
0
Life Sciences
AI-Powered Study Uncovers Hundreds of Previously Unknown Health Compounds in California Almonds
Life Sciences Times
-
July 11, 2025
0
Pharma
Early Study of Angelman Syndrome Drug Rugonersen Shows Promise, Published in Nature Medicine
Life Sciences Times
-
July 11, 2025
0
People on the Move
Energy Infrastructure and Environmental Expert Jamie Durand Joins GZA as Senior Consultant
Life Sciences Times
-
July 11, 2025
0
1
...
151
152
153
...
836
Page 152 of 836
Most Popular
WHOOP Expands Health Platform With Clinician Access and AI Features
May 8, 2026
Reprieve Cardiovascular Reports Published Pilot Trial Results for Heart Failure Therapy
May 8, 2026
Stoke Therapeutics Advances Dravet Syndrome Drug as Phase 3 Study Nears Enrollment Goal
May 8, 2026
Myomo Revenue Rises as Company Expands Recurring Patient Sources
May 8, 2026
Load more
Recent Comments
Recent Comments